These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Public interest in ∆ Leas EC; Nobles AL; Shi Y; Hendrickson E Int J Drug Policy; 2022 Mar; 101():103557. PubMed ID: 34952279 [TBL] [Abstract][Full Text] [Related]
6. Derived psychoactive cannabis products and 4/20 specials: An assessment of popular brands and retail price discounts in Fort Worth, Texas, 2023. Rossheim ME; LoParco CR; Berg CJ; Tillett KK; Trangenstein PJ; Henry D; Yockey RA; Livingston MD; Jernigan DH; Sussman SY Drug Alcohol Depend; 2024 Mar; 256():111119. PubMed ID: 38350186 [TBL] [Abstract][Full Text] [Related]
7. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina. Fernández N; Cappello MG; Quiroga PN Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612 [TBL] [Abstract][Full Text] [Related]
8. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis. Freeman TP; Craft S; Wilson J; Stylianou S; ElSohly M; Di Forti M; Lynskey MT Addiction; 2021 May; 116(5):1000-1010. PubMed ID: 33160291 [TBL] [Abstract][Full Text] [Related]
9. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada. Hammond D; Goodman S Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866 [No Abstract] [Full Text] [Related]
10. Using Transformer-Based Topic Modeling to Examine Discussions of Delta-8 Tetrahydrocannabinol: Content Analysis. Smith BP; Hoots B; DePadilla L; Roehler DR; Holland KM; Bowen DA; Sumner SA J Med Internet Res; 2023 Dec; 25():e49469. PubMed ID: 38127427 [TBL] [Abstract][Full Text] [Related]
12. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores. Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320 [TBL] [Abstract][Full Text] [Related]
13. Cannabidiol (CBD) product contamination: Quantitative analysis of Δ Johnson E; Kilgore M; Babalonis S Drug Alcohol Depend; 2022 Aug; 237():109522. PubMed ID: 35690015 [TBL] [Abstract][Full Text] [Related]
14. A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History. Berl V; Hurd YL; Lipshutz BH; Roggen M; Mathur EJ; Evans M Cannabis Cannabinoid Res; 2022 Dec; 7(6):777-789. PubMed ID: 35787693 [No Abstract] [Full Text] [Related]
15. Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys. Carey LM; Maguire DR; France CP Drug Alcohol Depend; 2023 Mar; 244():109787. PubMed ID: 36753805 [TBL] [Abstract][Full Text] [Related]
16. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis. Hutten NRPW; Arkell TR; Vinckenbosch F; Schepers J; Kevin RC; Theunissen EL; Kuypers KPC; McGregor IS; Ramaekers JG Psychopharmacology (Berl); 2022 Nov; 239(11):3731-3741. PubMed ID: 36227352 [TBL] [Abstract][Full Text] [Related]
17. What Do You Know About Maryjane? A Systematic Review of the Current Data on the THC:CBD Ratio. Zeyl V; Sawyer K; Wightman RS Subst Use Misuse; 2020; 55(8):1223-1227. PubMed ID: 32124675 [No Abstract] [Full Text] [Related]
18. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290 [TBL] [Abstract][Full Text] [Related]
19. The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment. Lawn W; Trinci K; Mokrysz C; Borissova A; Ofori S; Petrilli K; Bloomfield M; Haniff ZR; Hall D; Fernandez-Vinson N; Wang S; Englund A; Chesney E; Wall MB; Freeman TP; Curran HV Addiction; 2023 Jul; 118(7):1282-1294. PubMed ID: 36750134 [TBL] [Abstract][Full Text] [Related]
20. Acute effects of Δ Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]